Pancreatic Cancer Research

ResearcherComprehensive Cancer Center ViennaActive in the last 2 years

Cihan Ay

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2607-9717; OpenAlex author ID A5029467210. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B. Co-author DOI 10.3390/pharmaceutics16091207↗
  2. Plasma Clot Properties in Patients with Pancreatic Cancer. Last author DOI 10.3390/cancers15164030↗
  3. Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel. Co-author DOI 10.1055/a-1548-4847↗
  4. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer. Last author DOI 10.1161/atvbaha.121.316463↗
  5. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. Last author DOI 10.1182/bloodadvances.2020003149↗
  6. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Last author DOI 10.1016/j.trsl.2013.06.009↗
  7. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. First author DOI 10.1111/eci.12042↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingrid Pabinger · 5 shared papers, 2013–2023 · strength 0.60
  2. J. Thaler · 4 shared papers, 2013–2023 · strength 0.48
  3. Gerald W. Prager · 2 shared papers, 2021–2023 · strength 0.39
  4. Florian Moik · 3 shared papers, 2021–2022 · strength 0.37
  5. Nigel Mackman · 3 shared papers, 2013–2021 · strength 0.28
  6. Norbert H. Brockmeyer · 1 shared paper, 2024 · strength 0.24
  7. Emre Basar · 1 shared paper, 2024 · strength 0.24
  8. Yohei Hisada · 1 shared paper, 2021 · strength 0.12
  9. Tomohiro Kawano · 1 shared paper, 2021 · strength 0.12
  10. Matthew J. Flick · 1 shared paper, 2021 · strength 0.12
  11. Michael Stotz · 1 shared paper, 2022 · strength 0.12
  12. Armin Gerger · 1 shared paper, 2022 · strength 0.12
  13. Jakob Michael Riedl · 1 shared paper, 2022 · strength 0.12
  14. Martin Pichler Pichler · 1 shared paper, 2022 · strength 0.12
  15. Dominik Andreas Barth · 1 shared paper, 2022 · strength 0.12
  16. Konstantin Schlick · 1 shared paper, 2022 · strength 0.12
  17. Richard Greil · 1 shared paper, 2022 · strength 0.12
  18. Werner Scheithauer · 1 shared paper, 2013 · strength 0.03
  19. Michael Gnant · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.